JP2014527821A5 - - Google Patents

Download PDF

Info

Publication number
JP2014527821A5
JP2014527821A5 JP2014531048A JP2014531048A JP2014527821A5 JP 2014527821 A5 JP2014527821 A5 JP 2014527821A5 JP 2014531048 A JP2014531048 A JP 2014531048A JP 2014531048 A JP2014531048 A JP 2014531048A JP 2014527821 A5 JP2014527821 A5 JP 2014527821A5
Authority
JP
Japan
Prior art keywords
derived
adipose tissue
cells
use according
passaged
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014531048A
Other languages
English (en)
Japanese (ja)
Other versions
JP6162123B2 (ja
JP2014527821A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2012/001140 external-priority patent/WO2013040649A1/en
Publication of JP2014527821A publication Critical patent/JP2014527821A/ja
Publication of JP2014527821A5 publication Critical patent/JP2014527821A5/ja
Application granted granted Critical
Publication of JP6162123B2 publication Critical patent/JP6162123B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014531048A 2011-09-23 2012-09-21 脂肪細胞および細胞分泌物を使用する治療 Active JP6162123B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
AU2011903938A AU2011903938A0 (en) 2011-09-23 Therapeutic methods and compositions
AU2011903938 2011-09-23
AU2012901350A AU2012901350A0 (en) 2012-04-04 Therapeutic methods and compositions
AU2012901350 2012-04-04
AU2012903646 2012-08-23
AU2012903646A AU2012903646A0 (en) 2012-08-23 Therapeutic methods and compositions
PCT/AU2012/001140 WO2013040649A1 (en) 2011-09-23 2012-09-21 Therapeutics using adipose cells and cell secretions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017116648A Division JP6839038B2 (ja) 2011-09-23 2017-06-14 脂肪細胞および細胞分泌物を使用する治療

Publications (3)

Publication Number Publication Date
JP2014527821A JP2014527821A (ja) 2014-10-23
JP2014527821A5 true JP2014527821A5 (enExample) 2015-11-12
JP6162123B2 JP6162123B2 (ja) 2017-07-12

Family

ID=47913679

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2014531048A Active JP6162123B2 (ja) 2011-09-23 2012-09-21 脂肪細胞および細胞分泌物を使用する治療
JP2017116648A Expired - Fee Related JP6839038B2 (ja) 2011-09-23 2017-06-14 脂肪細胞および細胞分泌物を使用する治療
JP2019090715A Expired - Fee Related JP6912512B2 (ja) 2011-09-23 2019-05-13 脂肪細胞および細胞分泌物を使用する治療
JP2021111459A Expired - Fee Related JP7022863B2 (ja) 2011-09-23 2021-07-05 脂肪細胞および細胞分泌物を使用する治療
JP2021195358A Pending JP2022033865A (ja) 2011-09-23 2021-12-01 脂肪細胞および細胞分泌物を使用する治療

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2017116648A Expired - Fee Related JP6839038B2 (ja) 2011-09-23 2017-06-14 脂肪細胞および細胞分泌物を使用する治療
JP2019090715A Expired - Fee Related JP6912512B2 (ja) 2011-09-23 2019-05-13 脂肪細胞および細胞分泌物を使用する治療
JP2021111459A Expired - Fee Related JP7022863B2 (ja) 2011-09-23 2021-07-05 脂肪細胞および細胞分泌物を使用する治療
JP2021195358A Pending JP2022033865A (ja) 2011-09-23 2021-12-01 脂肪細胞および細胞分泌物を使用する治療

Country Status (9)

Country Link
US (3) US10111909B2 (enExample)
EP (3) EP2744892B1 (enExample)
JP (5) JP6162123B2 (enExample)
AU (1) AU2012313352B2 (enExample)
CA (1) CA2885487C (enExample)
DK (2) DK2744892T3 (enExample)
ES (2) ES2721180T3 (enExample)
SG (2) SG10201606745XA (enExample)
WO (1) WO2013040649A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9192695B2 (en) 2008-11-20 2015-11-24 Allosource Allografts combined with tissue derived stem cells for bone healing
JP2023002772A (ja) * 2011-09-23 2023-01-10 レジニアス リミテッド 脂肪細胞および細胞分泌物を使用する治療
SG10201606745XA (en) * 2011-09-23 2016-10-28 Cell Ideas Pty Ltd Therapeutics using adipose cells and cell secretions
AU2013204930C1 (en) * 2012-09-26 2015-01-22 Cell Ideas Pty Ltd Therapeutics using multiple injections of cells
EP2919794B1 (en) 2012-11-15 2021-01-20 AlloSource Minced cartilage systems and methods
EP3446708A1 (en) 2012-12-24 2019-02-27 Cell Ideas Pty Ltd. Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
US9186253B2 (en) * 2013-02-22 2015-11-17 Allosource Cartilage mosaic compositions and methods
WO2014151939A1 (en) 2013-03-15 2014-09-25 Allosource Perforated osteochondral allograft compositions
WO2014150784A1 (en) 2013-03-15 2014-09-25 Allosource Cell repopulated collagen matrix for soft tissue repair and regeneration
WO2014204806A2 (en) * 2013-06-19 2014-12-24 Spinalcyte, Llc Adipose cells for chondrocyte applications
KR20160073382A (ko) 2013-10-04 2016-06-24 셀 아이디어스 피티와이 엘티디 세포 치료를 위한 바이오마커들
AU2015367275B2 (en) * 2014-12-19 2021-11-18 Cell Ideas Pty Ltd Improved cell therapies
WO2017041133A1 (en) 2015-09-08 2017-03-16 Cell Ideas Pty Ltd Cell expansion methods and therapeutic compositions
CN108289915A (zh) * 2015-11-24 2018-07-17 日本乐敦制药株式会社 包含脂肪组织来源基质细胞的肝病治疗剂及其制造方法
EP3478300B1 (en) 2016-06-30 2022-08-24 Stem Cell Medicine Ltd. Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells
EP3624815A4 (en) 2017-05-15 2021-01-20 Stem Cell Medicine Ltd. TREATMENT OF MULTIPLE SCLEROSIS WITH LONG-ACTING GLATIRAMER AND ADAPTIVE STEM CELLS
IL269893B2 (en) 2017-05-15 2023-10-01 Stem Cell Medicine Ltd Treatment of multiple sclerosis with adipose-derived stem cells
KR20230117627A (ko) * 2017-10-02 2023-08-08 히로타로 후쿠오카 두피 혹은 피부의 개질, 창상 치유, 또는 모발의 개질에이용되기 위한 의약 조성물
KR20210021358A (ko) * 2018-06-15 2021-02-25 파르도 루이스 마리나스 약제학적 피부과 조성물 및 그 용도
WO2020036184A1 (ja) * 2018-08-14 2020-02-20 国立研究開発法人国立国際医療研究センター 褐色脂肪細胞上清、その調製法、及び、使用
JP7429032B2 (ja) * 2019-12-24 2024-02-07 学校法人順天堂 間質性肺炎モデル非ヒト動物の作製方法
JP6826744B1 (ja) * 2020-07-17 2021-02-10 医療法人Yanaga CLinic 成熟脂肪細胞含有組成物の製造方法
CN114452303B (zh) * 2020-11-10 2025-05-30 上海萨美细胞技术有限公司 无细胞脂肪提取液对关节炎的治疗用途
IT202100003062A1 (it) * 2021-02-11 2022-08-11 Gaia Margiotta "processo di crioconservazione di tessuto adiposo"
JP7057006B1 (ja) * 2021-04-12 2022-04-19 医療法人社団サカイクリニック62 歯周組織用製剤及びそれを含むキット
US12636408B2 (en) 2021-08-12 2026-05-26 Britecyte Inc. Adipose compositions and methods of use thereof
CN115521908A (zh) * 2022-10-24 2022-12-27 潍坊天创生物科技有限公司 一种脂肪间充质干细胞的体外培养及外泌体的分离纯化方法
US12570949B2 (en) 2022-12-27 2026-03-10 AVITA Medical Americas, LLC Systems and devices for wound therapy and related methods of use
DE202023002794U1 (de) 2022-12-27 2024-07-15 AVITA Medical Americas, LLC Kassette zur Herstellung einer regenerativen epidermalen Suspension
USD1112812S1 (en) 2023-12-22 2026-02-10 AVITA Medical Americas, LLC Tissue processing cartridge
CN118105463B (zh) * 2024-02-27 2025-05-30 上海萨美细胞技术有限公司 脂肪脱细胞活性蛋白在抗阿尔兹海默症中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037175A (en) 1996-03-12 2000-03-14 The University Of South Florida Method and media for enhancing cryopreservation of cells
US7078232B2 (en) * 1999-08-19 2006-07-18 Artecel, Inc. Adipose tissue-derived adult stem or stromal cells for the repair of articular cartilage fractures and uses thereof
US20030054331A1 (en) 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
CN1596303A (zh) * 2001-11-09 2005-03-16 阿特塞尔科学公司 利用基质细胞支持胚胎干细胞和成体干细胞的方法和组合物
CA2469370C (en) * 2001-12-07 2014-07-08 Macropore Biosurgery, Inc. Adipose-derived cell processing unit
AU2004280616A1 (en) * 2003-10-08 2005-04-21 Vet-Stem Inc. Methods of preparing and using stem cell compositions and kits comprising the same
US8715733B2 (en) * 2004-07-23 2014-05-06 DePuy Synthes Products, LLC Enhanced adipose tissue
US20100092432A1 (en) * 2006-08-08 2010-04-15 Takenori Ozaki Cell preparation containing multipotential stem cells originating in fat tissue
AU2007320031B2 (en) * 2006-10-06 2013-05-02 University Of Virginia Patent Foundation Methods and compositions useful for diabetic wound healing
US8481253B2 (en) * 2008-03-19 2013-07-09 Cryo-Save Ag Cryopreservation of adipose tissue for the isolation of mesenchymal stem cells
US9144584B2 (en) 2008-06-11 2015-09-29 Cell4Vet Corporation Adipose tissue-derived stem cells for veterinary use
AU2009201915C1 (en) 2008-08-22 2015-02-26 Regeneus Ltd Therapeutic methods
WO2010126194A1 (ko) * 2009-04-28 2010-11-04 (주) 안트로젠 누공 치료를 위한 자가 및 동종의 지방 유래 스트로마 줄기세포 조성물
WO2011047345A2 (en) * 2009-10-15 2011-04-21 Tai June Yoo Methods of treating diseases of conditions using mesenchymal stem cells
WO2012122604A1 (en) * 2011-03-15 2012-09-20 Cell Ideas Pty Ltd Pharmaceutical compositions and topical use thereof
SG10201606745XA (en) * 2011-09-23 2016-10-28 Cell Ideas Pty Ltd Therapeutics using adipose cells and cell secretions

Similar Documents

Publication Publication Date Title
ES2880084T3 (es) Terapias que usan células adiposas y secreciones celulares
Eom et al. Mesenchymal stem cell therapy for cirrhosis: present and future perspectives
EA201490512A1 (ru) Композиции, содержащие культивируемую в анаэробных условиях микробиоту кишечника человека
EP3419635B1 (en) Pharmaceutical or veterinary cell compositions comprising mesenchymal stromal cells (mscs) and dimethyl sulfoxide (dmso)
BR112013004917A2 (pt) terapias de células tronco alogênicas sistêmicas para tratamento de doenças em animais.
AR093217A1 (es) Anticuerpos antagonistas mejorados contra factor-8 de crecimiento y diferenciacion y usos de los mismos
WO2012065027A3 (en) Compositions, kits and methods for treatment of cardiovascular, immunological, and inflammatory diseases
Mansilla et al. Could metabolic syndrome, lipodystrophy, and aging be mesenchymal stem cell exhaustion syndromes?
WO2010082787A3 (ko) 연골줄기세포를 유효성분으로 포함하는 골질환 치료용 또는 항염증용 약제학적 조성물
MY170630A (en) Freeze-dried formulations of fgf-18
Huang et al. NKT cells mediate the recruitment of neutrophils by stimulating epithelial chemokine secretion during colitis
CN105214087A (zh) Pcsk9单克隆抗体在制备治疗炎症免疫性疾病药物中的应用
Liang et al. Autologous transplantation of adipose-derived stromal cells ameliorates ventilator-induced lung injury in rats
Chen et al. Current state of heart failure treatment: are mesenchymal stem cells and their exosomes a future therapy?
Gherghel et al. Osteoarthritis—the role of mesenchymal stem cells in cartilage regeneration
JP2018501241A5 (enExample)
JP2012507997A5 (enExample)
TW201613621A (en) Composition for promoting growth of dermal papilla cells, pharmaceutical composition, and preparation method thereof
WO2009015279A3 (en) Agents and methods for inhibition of airway hyperresponsiveness
Tremolada Mesenchymal stem cells and regenerative medicine: how Lipogems technology make them easy, safe and more effective to use
Kim et al. Adipose-derived Stem Cell-Based Immunomodulatory Therapy in a Translational Porcine Limb Transplant Model
Chow et al. Interaction of iPSC-derived MSCs with the gastrointestinal tract and microbiome in the management of inflammatory bowel disease
CN104488827A (zh) 一种利用鸡粪养殖蚯蚓的方法
Al-Agelea et al. THE POTENTIALITY OF MESENCHYMAL STEM CELLS IN THE REHABILITATION OF EQUINE TENDONITIS
WO2016018454A3 (en) Compositions and methods employing bcl2 and bcl2 family members